Can a pill reach brain tumors? new trial tests ribociclib before surgery

NCT ID NCT02933736

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether the drug ribociclib can reach brain tumors in people with recurrent high-grade glioma or meningioma. About 48 participants take the drug before their scheduled tumor-removal surgery. The goal is to measure how much drug gets into the tumor and surrounding brain tissue, not to treat the disease directly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ribociclib (a targeted cancer drug taken as a pill)

What this could lead to

If it works, this could show that ribociclib reaches brain tumors effectively, pointing toward a new treatment option for these hard-to-treat cancers.

What could go wrong

This is a very early, small study (48 people) focused on drug penetration, not on curing the disease. The drug may not work well enough or could have side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glioblastoma glioma susceptibility 1 malignant glioma meningioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barrow Brain and Spine

    Phoenix, Arizona, 85013, United States